InMode Ltd. logo

InMode Ltd.

INMD | NASDAQ
Chart Builder DCF Calculator
$14.50
+$0.15 (+1.05%)
At close: Sep 21, 2026, 4:00 PM ET
$14.55
+$0.05 (+0.34%)
Pre-market: Sep 22, 2026, 9:21 AM ET

Company Profile

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.

Key Executives

Name Position
Moshe Mizrahy Co-Founder, Chief Executive Officer & Director
Michael Kreindel Co-Founder, Chief Technology Officer & Director
Moshik Itzkovich Chief Financial Officer
Nava Tal-Launer Chief Information Officer
Brandon Nye Vice President of Sales of West US
Matt Rodgers Vice President of Sales of Canada
Michael Dennison President of North America
Yair Malca Consultant

Latest SEC Filings

Date Type Title
Aug 11, 2026 6-K Filing
Aug 05, 2026 SC 13D/A [Amend] Filing
Aug 05, 2026 4 Filing
Aug 05, 2026 6-K Filing
Aug 03, 2026 6-K Filing
Jul 30, 2026 4 Filing
Jul 30, 2026 4 Filing
Jul 30, 2026 4 Filing
Jul 20, 2026 6-K Filing
Jul 13, 2026 6-K Filing
View All SEC Filings
InMode Ltd.
InMode Ltd. logo
Country Israel
IPO Date Aug 7, 2019
Industry Medical - Devices
Sector Healthcare
Employees 660
CEO Moshe Mizrahy

Contact Details

Tavor Building Yokne'am, TA 2069206 Israel

Stock Details

Ticker Symbol INMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001742692
CUSIP Number M5425M103
ISIN Number IL0011595993
SIC Code 3845

© 2026 bestshares.com. All rights reserved.